JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v10i4.14798ArticleResearch Review on Early Diagnostic Markers and Intervention Strategies for Liver Fibrosis https://artdesignp.com/journal/JCNR/10/4/10.26689/jcnr.v10i4.14798YuGuodong,BaiXuefeng20261042026-04-30Liver fibrosis represents a pivotal intermediate pathological stage in the progression from various chronic liver diseases to cirrhosis and hepatocellular carcinoma, characterized primarily by persistent hepatocyte injury leading to the activation of hepatic stellate cells, which subsequently results in excessive extracellular matrix deposition and hepatic tissue structural remodeling. Early-stage liver fibrosis is fully reversible; however, once it advances to late-stage fibrosis or cirrhosis, the difficulty of reversal significantly increases. Therefore, early and accurate diagnosis, coupled with timely intervention, is crucial for improving the prognosis of patients with chronic liver diseases and reducing mortality from end-stage liver diseases. This article systematically reviews current markers for the early diagnosis of liver fibrosis and summarizes mainstream intervention strategies, providing theoretical references and clinical practice evidence for the early diagnosis and treatment of liver fibrosis.

Li M, Zhang W, 2025, Research Progress on Integrated Traditional Chinese and Western Medicine for Chronic Liver Disease Complicated with Depression and Anxiety. Journal of Integrated Traditional Chinese and Western Medicine on Liver Diseases, 35(01): 109–114.

Mo Y, Zhou X, Sun D, et al., 2025, Research Status on the Relationship Between Liver Hypoxic Microenvironment and the Occurrence and Development of Liver Cirrhosis. Journal of Integrated Traditional Chinese and Western Medicine on Liver Diseases, 35(09): 1181–1185.

Zhang D, Zhou H, 2025, Immune Regulation in the Process of Liver Fibrosis. China Basic Science, 27(04): 10–18.

Tian H, Feng Q, Hu Y, 2016, Research Status on Non-Invasive Diagnosis of Liver Fibrosis. Shanghai Medical and Pharmaceutical Journal, 37(13): 24–28 + 36.

Wang Z, Qiu Q, Wu Y, et al., 2026, Research Progress on Non-Invasive and Accurate Diagnostic Techniques for Liver Fibrosis. China Medical Herald, 23(02): 157–161.

Lu L, You H, Xie W, et al., 2019, Consensus on the Diagnosis and Treatment of Liver Fibrosis (2019). Journal of Practical Liver Diseases, 22(06): 793–803.

Dai C, Tang Y, 2023, Application Value of Serum Chitinase 3-Like Protein 1 in Liver Diseases and Other Diseases. Modern Digestion & Intervention, 28(12): 1467–1470 + 1474.

Zhou Q, Li D, Ye J, et al., 2022, Diagnostic Value of Serum Chitinase 3-Like Protein 1 Combined with Two-Dimensional Real-Time Shear Wave Elastography for Significant Liver Fibrosis/Cirrhosis in Chronic Liver Diseases. Modern Digestion & Intervention, 27(06): 766–770.

Qiu X, Jiang A, 2014, Research Progress on GP73 and Digestive System Diseases. Progress in Modern Biomedicine, 14(04): 786–788.

Wu X, Liu H, Liu F, et al., 2026, Application of Imaging Techniques in the Surgical Diagnosis and Treatment of Liver Cancer. China Journal of Modern Medicine, 36(05): 62–68.

Xu F, Sheng Q, 2018, Research Progress on the Evaluation of Liver Fibrosis Using Serum Markers and Transient Elastography. Journal of Clinical Hepatology, 34(03): 618–622.

Yang S, Zhao X, Zhao L, et al., 2026, Value of IVIM, DKI, and Their Combination with Ultrasonic Transient Elastography in the Staging of Liver Fibrosis in Patients with Chronic Liver Diseases. Magnetic Resonance Imaging, 17(02): 94–100.

Zhu F, Zhang R, Liu G, 2022, Relationship Between Liver Fibrosis Markers, Traditional Chinese Medicine Syndromes, and Multi-Slice Spiral CT Perfusion Imaging Parameters in Patients with Chronic Hepatitis B. Liaoning Journal of Traditional Chinese Medicine, 49(09): 134–137 + 223.

Xiao L, Li K, Yang M, et al., 2025, Research Progress on the Application of Lipidomics in Metabolic (Non-Alcoholic) Steatohepatitis. World Science and Technology-Modernization of Traditional Chinese Medicine, 27(11): 3362–3372.

Wu Y, Tian S, 2026, Research Status on Inhibitors Targeting the TGF-β Signaling Pathway in the Intervention of Liver Fibrosis. Pharmaceutical Frontiers, 30(02): 347–360.

Ding L, Du F, Hu J, et al., 2025, Influencing Factors of Low-Level Viremia After Nucleoside (Nucleotide) Analog Therapy in Patients with Chronic Hepatitis B. Journal of Xinxiang Medical College, 42(12): 977–982.

Wang L, 2014, Evaluation of the Effect of Dietary Nursing Intervention on the Rehabilitation of Liver Cirrhosis Patients Complicated with Diabetes. Chinese Community Doctors, 30(19): 141–142.

Chen J, Wang X, Tang S, 2024, Research Progress on the Application of Azathioprine in Autoimmune Liver Diseases. Journal of Gastroenterology and Hepatology, 33(07): 926–929.

Wei P, Feng J, Li Y, et al., 2025, Research Status on the Mechanism of Action of Pirfenidone and Its Application in Fibrotic Diseases. Jilin Medical Journal, 46(05): 1188–1192.

Shao W, Lu R, Wang G, et al., 2025, Effects of Ursodeoxycholic Acid Combined with Diammonium Glycyrrhizinate Enteric-Coated Capsules on Serum Inflammatory Factors, Liver Fibrosis, and Adverse Reactions in Patients with Chronic Hepatitis B. Tianjin Pharmacy, 37(09): 1042–1045.

Zhang P, Zheng S, Gou S, et al., 2024, Mechanism of Action of Traditional Chinese Medicine Formulas in Reversing Liver Fibrosis and Early Liver Cirrhosis. Journal of Clinical Hepatology, 40(09): 1873–1879.

Wang M, Zhu Y, Yang X, et al., 2025, Expert Consensus on Non-Traumatic Laboratory Diagnosis of Liver Fibrosis. Laboratory Medicine, 40(07): 625–641.

Zhang D, Mao X, Wang X, et al., 2026, Application Effect of Home-School Collaborative Intervention Combined with Comic Illustration Manual Education in Obese Children with Non-Alcoholic Fatty Liver Disease. Nursing Practice and Research, 23(03): 359–367.

Deng X, Jiang R, Li X, 2026, Research Progress on the Role of Intestinal Microbiota Imbalance in the Pathogenesis and Targeted Intervention of Liver Cancer. Acta Microbiologica Sinica, 66(03): 975–989.

Jiang Y, Wang L, Wang H, 2025, Research Progress on the Treatment of Autoimmune Hepatitis Based on Mesenchymal Stem Cells. Military Medical Sciences, 49(12): 940–948.

Yang J, Wang H, Zheng Z, et al., 2026, Research Progress on the Role and Mechanism of Traditional Chinese Medicine in Preventing and Treating Radiation-Induced Lung Injury Based on the TGF-β/Smad Signaling Pathway. China Journal of Modern Applied Pharmacy: 1–11.